Status:
COMPLETED
Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection
Lead Sponsor:
University of California, San Diego
Collaborating Sponsors:
National Institutes of Health (NIH)
Centers for Disease Control and Prevention
Conditions:
Acute HIV Infection
Eligibility:
All Genders
13+ years
Phase:
NA
Brief Summary
The investigators propose to study the impact of nucleic acid amplification testing (NAT) screening for acute Human Immunodeficiency Virus (HIV) and Hepatitis C (HCV) infections and Less-Sensitive Enz...
Eligibility Criteria
Inclusion
- Persons presenting for HIV testing to Public Health Department HIV testing site.
- Men and women \>13 years of age.
- Those who are 13 or older and younger than 18 should be an emancipated minor or have consent given by their legal representative.
- Participants 18 and over must be able to provide written consent.
- Participants should be available for follow up for a period of at least 2 weeks after enrollment
Exclusion
- Refusal to participate.
- Unable to provide informed consent.
Key Trial Info
Start Date :
September 16 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 7 2015
Estimated Enrollment :
22607 Patients enrolled
Trial Details
Trial ID
NCT01434706
Start Date
September 16 2010
End Date
April 7 2015
Last Update
October 21 2019
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Christie's Place
San Diego, California, United States, 92101
2
San Diego LGBT Community Center
San Diego, California, United States, 92103
3
UC San Diego Antiviral Research Center
San Diego, California, United States, 92103
4
UCSD Lead the Way Storefront
San Diego, California, United States, 92103